ATE59046T1 - Bizyklische diphosphonat-verbindungen und arzneimittel. - Google Patents

Bizyklische diphosphonat-verbindungen und arzneimittel.

Info

Publication number
ATE59046T1
ATE59046T1 AT87202533T AT87202533T ATE59046T1 AT E59046 T1 ATE59046 T1 AT E59046T1 AT 87202533 T AT87202533 T AT 87202533T AT 87202533 T AT87202533 T AT 87202533T AT E59046 T1 ATE59046 T1 AT E59046T1
Authority
AT
Austria
Prior art keywords
present
bicyclic
pharmaceuticals
relates
compounds
Prior art date
Application number
AT87202533T
Other languages
English (en)
Inventor
Frank Hallock Ebetino
Kent Warren Buckingham
Jocelyn Elaine Mcosker
Original Assignee
Norwich Eaton Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Norwich Eaton Pharma filed Critical Norwich Eaton Pharma
Application granted granted Critical
Publication of ATE59046T1 publication Critical patent/ATE59046T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/553Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
    • C07F9/576Six-membered rings
    • C07F9/5765Six-membered rings condensed with carbocyclic rings or carbocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Paints Or Removers (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Steroid Compounds (AREA)
AT87202533T 1986-12-19 1987-12-16 Bizyklische diphosphonat-verbindungen und arzneimittel. ATE59046T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/945,069 US4868164A (en) 1986-12-19 1986-12-19 Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
EP87202533A EP0273514B1 (de) 1986-12-19 1987-12-16 Bizyklische Diphosphonat-Verbindungen und Arzneimittel

Publications (1)

Publication Number Publication Date
ATE59046T1 true ATE59046T1 (de) 1990-12-15

Family

ID=25482572

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87202533T ATE59046T1 (de) 1986-12-19 1987-12-16 Bizyklische diphosphonat-verbindungen und arzneimittel.

Country Status (18)

Country Link
US (3) US4868164A (de)
EP (1) EP0273514B1 (de)
JP (1) JP2573973B2 (de)
KR (1) KR950009196B1 (de)
AT (1) ATE59046T1 (de)
AU (1) AU615886B2 (de)
CA (1) CA1321793C (de)
DE (1) DE3766695D1 (de)
DK (1) DK171068B1 (de)
FI (1) FI87652C (de)
HK (1) HK79393A (de)
IE (1) IE873456L (de)
IL (1) IL84660A (de)
MY (1) MY102266A (de)
NO (2) NO174625C (de)
NZ (1) NZ222985A (de)
PH (1) PH25583A (de)
ZA (1) ZA879502B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
DE3822650A1 (de) * 1988-07-05 1990-02-01 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US5753634A (en) * 1992-05-29 1998-05-19 The Procter & Gamble Company Quaternary nitrogen containing phosphonate compounds, pharmaceutical compostions, and methods for treating abnormal calcium and phosphate metabolism
ATE195317T1 (de) * 1992-05-29 2000-08-15 Procter & Gamble Pharma Schwefel-enthaltende phosphonat-verbindungen zur behandlung von abnormalem calzium- und phosphat- metabolismus
HUT69731A (en) * 1992-05-29 1995-09-28 Procter & Gamble Pharma Thio-substituted nitrogen-containing heterocyclic phosphonate compounds for treating abnormal calcium and phosphate metabolism
US5391743A (en) * 1992-05-29 1995-02-21 Procter & Gamble Pharmaceuticals, Inc. Quaternary nitrogen-containing phosphonate compounds, pharmaceutical compositions, and methods of treating abnormal calcium and phosphate metabolism and methods of treating and preventing dental calculus and plaque
DK0646119T3 (da) * 1992-05-29 1998-12-14 Procter & Gamble Pharma Phosphonatforbindelser indeholdende kvaternært nitrogen til behandling af unormalt calcium- og phosphatstofskifte samt tan
US5763611A (en) * 1992-05-29 1998-06-09 The Procter & Gamble Company Thio-substituted cyclic phosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism
CA2138366C (en) * 1992-06-30 1998-09-22 Kristine Hovancik Methods for the treatment of arthritis using phosphonates and nsaids
CN1157565A (zh) * 1994-09-09 1997-08-20 普罗克特和甘保尔公司 用骨活性膦酸盐和甲状旁腺激素治疗骨质疏松症的方法
EP0753523A1 (de) 1995-07-10 1997-01-15 Gador S.A. Amino-substuierte bisphosphonsäure
US7781418B2 (en) * 2006-12-14 2010-08-24 Isis Innovation Ltd. Composition for treating bone disorders
US11793452B2 (en) 2019-10-03 2023-10-24 Johnson & Johnson Consumer Inc. Method of visualizing and quantifying remineralization

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3553314A (en) * 1968-12-23 1971-01-05 Procter & Gamble Oral compositions for calculus retardation
DE1958123C3 (de) * 1969-11-19 1978-09-28 Henkel Kgaa, 4000 Duesseldorf Verfahren zur Herstellung von 1 -Aminoalkan-1,1 -diphosphonsäuren oder deren Salzen
US3979385A (en) * 1969-11-19 1976-09-07 Henkel & Cie G.M.B.H. 1-Aminoalkane-1,1-diphosphonic acids and their salts
US3683080A (en) * 1970-08-28 1972-08-08 Procter & Gamble Compositions for inhibiting anomalous deposition and mobilization of calcium phosphate in animal tissue
US3899496A (en) * 1970-10-06 1975-08-12 Henkel & Cie Gmbh Production of 1-aminoalkane-1,1-diphosphonic acids
DE2104476C2 (de) * 1971-02-01 1983-12-01 Henkel KGaA, 4000 Düsseldorf Verfahren zur Verhinderung von Ausfällungen in Wasser oder wäßrigen Lösungen
US3988443A (en) * 1973-08-27 1976-10-26 Henkel & Cie G.M.B.H. Azacycloalkane-2,2-diphosphonic acids
US4034086A (en) * 1973-08-27 1977-07-05 Henkel & Cie G.M.B.H. Pyrrolidone-5,5-diphosphonic acids
DE2343196C3 (de) * 1973-08-27 1980-01-10 Henkel Kgaa, 4000 Duesseldorf Aiacycloalkan-2^-diphosphonsäuren oder deren wasserlösliche Salze
DE2343147C2 (de) * 1973-08-27 1982-06-09 Henkel KGaA, 4000 Düsseldorf Pyrrolidon-5,5-diphosphonsäuren, deren wasserlösliche Salze, und Verfahren zu ihrer Herstellung
DE2456666A1 (de) * 1974-11-30 1976-08-12 Henkel & Cie Gmbh Verfahren zum stabilisieren von calcium-hydrogenphosphat-dihydrat gegen hydrolyse
DE2543349C2 (de) * 1975-09-29 1984-05-10 Henkel KGaA, 4000 Düsseldorf Preaparate zur herstellung von99m technetium-radiagnostica
SE7612534L (sv) * 1975-12-01 1977-06-02 Henkel & Cie Gmbh Forfarande for framstellning av farmaceutiska preparat for behandling av storningar i kalciumemnesomsettning
DE2745083C2 (de) * 1977-10-07 1985-05-02 Henkel KGaA, 4000 Düsseldorf Hydroxydiphosphonsäuren und Verfahren zu deren Herstellung
US4230700A (en) * 1977-12-07 1980-10-28 The Procter & Gamble Company Methods for inhibiting mobilization of calcium phosphate in animal tissue
SU1002300A1 (ru) * 1981-10-29 1983-03-07 Ордена Ленина институт элементоорганических соединений им.А.Н.Несмеянова Способ получени @ -аминозамещенных- @ -оксипропилидендифосфоновых кислот
DE3428524A1 (de) * 1984-08-02 1986-02-13 Boehringer Mannheim Gmbh, 6800 Mannheim Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4687768A (en) * 1984-12-21 1987-08-18 The Procter & Gamble Company Certain hexahydroindan-2,2-diphosphonic acids useful in treating diseases associated with abnormal calcium and phosphate metabolism
DE3540150A1 (de) * 1985-11-13 1987-05-14 Boehringer Mannheim Gmbh Neue diphosphonsaeurederivate, verfahren zu deren herstellung und diese verbindungen enthaltende arzneimittel
US4868164A (en) * 1986-12-19 1989-09-19 Norwich Eaton Pharmaceuticals, Inc. Octahydro-pyridine diphosphonate compounds, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism

Also Published As

Publication number Publication date
FI875595A0 (fi) 1987-12-18
DK670387A (da) 1988-06-20
IL84660A0 (en) 1988-04-29
FI87652C (fi) 1993-02-10
NO176144C (no) 1995-02-08
CA1321793C (en) 1993-08-31
NO922565D0 (no) 1992-06-29
AU8280987A (en) 1988-06-23
KR950009196B1 (ko) 1995-08-16
KR880007473A (ko) 1988-08-27
DK670387D0 (da) 1987-12-18
NO176144B (no) 1994-10-31
AU615886B2 (en) 1991-10-17
EP0273514B1 (de) 1990-12-12
NZ222985A (en) 1990-09-26
FI87652B (fi) 1992-10-30
NO174625C (no) 1994-06-08
MY102266A (en) 1992-05-15
ZA879502B (en) 1988-06-16
HK79393A (en) 1993-08-13
NO922565L (no) 1988-06-20
US4868164A (en) 1989-09-19
IE873456L (en) 1988-06-19
US5393746A (en) 1995-02-28
EP0273514A1 (de) 1988-07-06
NO875305D0 (no) 1987-12-18
FI875595A (fi) 1988-06-20
PH25583A (en) 1991-08-08
US5137880A (en) 1992-08-11
JPS63239290A (ja) 1988-10-05
DK171068B1 (da) 1996-05-20
NO174625B (no) 1994-02-28
JP2573973B2 (ja) 1997-01-22
IL84660A (en) 1994-10-21
NO875305L (no) 1988-06-20
DE3766695D1 (de) 1991-01-24

Similar Documents

Publication Publication Date Title
PH25769A (en) Certain cycloalkane-1,1-diphosphonic acids, derivatives thereof having the ability to treat diseases associated with abnormal calcium, phosphate metabolism
LU90669I2 (fr) Actonel
AU1876788A (en) Methylene phosphonoalkylphosphinates, pharmaceutical compositions , and methods for treating abnormal calcium and phosphate metabolism
ATE59046T1 (de) Bizyklische diphosphonat-verbindungen und arzneimittel.
MY103850A (en) Phenol substituted gem-diphosphonate derivatives, process for their preparation and pharmaceutical compositions containing them.
NZ225660A (en) Individual optical isomers of 2-methylspiro-(1,3-oxathiolan-5,3')-quinuclidine, and pharmaceutical compositions containing such

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee